The Food and Drug Administration (FDA) will be holding a public meeting in the fall of this year, designed to gather information about current developments in uses of nanotechnology materials in FDA regulated products. The FDA asks that those interested in presenting at or attending the meeting inform the agency of their interest.

Due to the small size and special properties of nanotechnology materials, they have great potential for use in a vast array of FDA-regulated products.

FDA is holding this meeting to further its understanding of developments in nanotechnology and, more specifically, to hear:

About the new types of nanotechnology products under development in the areas of foods (including dietary supplements), food and color additives, animal feeds, cosmetics, human and animal drugs and human biologics and medical devices;

About any specific scientific issues related to the development of these products relevant to FDA's regulation of them;

Any other issues about which regulated industry, academia, and the interested public may wish to inform FDA concerning the use of nanotechnology in FDA-regulated products; and

If there are opportunities for the agency to address hurdles that may be inhibiting the use of nanotechnology in medical product development.

The full story and information on how to inform the agency of your interest are available at FDA News.